LNAI vs UTHR · rev $20.9K vs P/E 20, rev $1.56B
Lunai Bioworks Inc. (LNAI) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Lunai Bioworks Inc. (LNAI) is a biotechnology company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LNAI revenue for 2026-03-31 was $20.9K. Net income was -$1.6M. LNAI currently screens at market cap $12.4M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
LNAI currently screens at market cap $12.4M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the LNAI and UTHR stock pages for the full models.
Not investment advice.